Cancer screening adherence
Publication
, Journal Article
Gierisch, JM; Bastian, LA
December 1, 2010
Cancer is a devastating and debilitating disease. Each year more than 1.4 million people are diagnosed with non-skin cancers and 565,650 lives are lost in the United States [1]. Primary prevention of cancer through behavioral modifications in risk factors such as tobacco use, sun exposure, obesity, physical inactivity, unhealthy diet, and alcohol consumption can reduce the burden of cancer tremendously [2, 3]. However, beyond the small proportion of cancers linked to genetic mutations, many cancers are sporadic. Early detection via evidence-based screening tests (i.e., secondary prevention) remains an effective option for controlling the burden of cancer [4]. © 2010 Springer Science+Business Media, LLC.
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Gierisch, J. M., & Bastian, L. A. (2010). Cancer screening adherence, 123–150. https://doi.org/10.1007/978-1-4419-5866-2_6
Gierisch, J. M., and L. A. Bastian. “Cancer screening adherence,” December 1, 2010, 123–50. https://doi.org/10.1007/978-1-4419-5866-2_6.
Gierisch JM, Bastian LA. Cancer screening adherence. 2010 Dec 1;123–50.
Gierisch, J. M., and L. A. Bastian. Cancer screening adherence. Dec. 2010, pp. 123–50. Scopus, doi:10.1007/978-1-4419-5866-2_6.
Gierisch JM, Bastian LA. Cancer screening adherence. 2010 Dec 1;123–150.